Checkpoint Trends Ltd - Stock Valuation and Financial Performance

BSE: 531099 | NSE: | Trading | Small Cap

Rubra Medicaments Share Price

13.26 -0.27 -2.00%
as on 21-Nov'24 16:59

DeciZen - make an informed investing decision on Rubra Medicaments

M-Cap below 100cr DeciZen not available

Checkpoint Trends stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
7.4 Cr.
52-wk low:
4.1
52-wk high:
17.5

Is Checkpoint Trends Ltd an attractive stock to invest in?

1. Is Checkpoint Trends Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Checkpoint Trends Ltd is a below average quality company.

2. Is Checkpoint Trends Ltd undervalued or overvalued?

The key valuation ratios of Checkpoint Trends Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Checkpoint Trends Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Checkpoint Trends Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Rubra Medicaments:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Checkpoint Trends Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % -150.5%-1.8%9.1%-32.2%-1.9%8%1.4%-3.7%-13.1%3.8%-
Value Creation
Index
-11.8-1.1-0.4-3.3-1.1-0.4-0.9-1.3-1.9-0.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00.20.32.30.610.521.21.11
Sales YoY Gr.-NA55%641.9%-74.4%67.8%-50.5%310.2%-42.3%-2.6%-
Adj EPS -1.8-00.10.1-0.200-0.1-0.10.1-0.4
YoY Gr.-NANA16.7%-442.9%NA-50%-800%NANA-
BVPS (₹) 0.70.70.80.50.40.50.50.50.310.9
Adj Net
Profit
-1000-0.1000-0.100
Cash Flow from Ops. -0.1000.200.10.5-0.500-
Debt/CF from Ops. 0000000010.70-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA13.9%32.1%-2.6%
Adj EPS NANA81.7%NA
BVPS3.5%17.1%23.9%223.3%
Share Price 14% 33.2% 74.6% 193.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
-50.6-1.88.57.5-22.41.70.9-6.1-14.55.8-36.7
Op. Profit
Mgn %
0-3.511.2-1.5-30.71.82.1-1.1-6.82.6-22.7
Net Profit
Mgn %
0-3.511.11.7-22.211.2-1.8-6.82.7-24.2
Debt to
Equity
000000000.900
Working Cap
Days
065543767314236418108218228263
Cash Conv.
Cycle
033-21121229419280172183227

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 32.12%

Sales growth is good in last 4 quarters at 83.92%

Return on Equity is Poor

Latest Financials - Checkpoint Trends Ltd.

Standalone Consolidated
TTM EPS (₹) -0.4 -
TTM Sales (₹ Cr.) 0.8 -
BVPS (₹.) 0.9 -
Reserves (₹ Cr.) -5 -
P/BV 14.43 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 4.09 / 17.45
All Time Low / High (₹) 0.96 / 78.90
Market Cap (₹ Cr.) 7.4
Equity (₹ Cr.) 5.5
Face Value (₹) 10
Industry PE 69

Management X-Ray of Rubra Medicaments:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Rubra Medicaments

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales00.200.312.300.590.990.492.011.161.13
Operating Expenses 0.070.200.272.330.770.970.482.031.241.10
Manufacturing Costs0000.160.01000.170.190.01
Material Costs00.130.121.890.330.150.080.5200
Employee Cost 00.020.020.130.210.130.200.230.350.50
Other Costs 0.070.060.130.160.230.690.201.120.700.59
Operating Profit -0.07-0.010.03-0.03-0.180.020.01-0.02-0.080.03
Operating Profit Margin (%) --3.5%11.2%-1.5%-30.7%1.8%2.1%-1.1%-6.8%2.5%
Other Income 0000.16000000
Interest 0000000000
Depreciation 0000000000.01
Exceptional Items -300-0.290.170.030000
Profit Before Tax -3.07-0.010.03-0.16-0.010.050.01-0.02-0.080.02
Tax 000000.0100.010-0.01
Profit After Tax -3.07-0.010.03-0.16-0.010.030.01-0.04-0.080.03
PAT Margin (%) --3.5%11.1%-7.1%-1.9%3.2%1.2%-1.8%-6.8%2.7%
Adjusted EPS (₹)-5.60.00.1-0.30.00.10.0-0.1-0.10.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 0.390.380.420.250.240.270.280.240.170.53
Share Capital 5.475.475.475.475.475.475.475.475.475.47
Reserves -5.08-5.08-5.05-5.21-5.23-5.19-5.19-5.22-5.30-4.94
Minority Interest0000000000
Debt000000000.150
Long Term Debt0000000000
Short Term Debt000000000.150
Trade Payables000.030.170.0600000
Others Liabilities 0.070.070.080.390.400.480.620.600.350.39
Total Liabilities 0.470.460.530.810.700.750.900.850.660.93

Fixed Assets

Gross Block00000.020.020.020.020.070.08
Accumulated Depreciation000000000.010.01
Net Fixed Assets00000.020.020.010.010.060.07
CWIP 0000000000
Investments 0000000000
Inventories0000000000
Trade Receivables0.020.020.020.340.290.290.220.670.430.71
Cash Equivalents 0.130.100.160.340.1400.520.020.030.01
Others Assets0.320.350.350.130.250.450.150.150.140.14
Total Assets 0.470.460.530.810.700.750.900.850.660.93

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity -0.08-0.010.040.18-0.030.120.52-0.500.01-0.02
PBT -0.07-0.010.030.12-0.180.020.01-0.02-0.080.02
Adjustment 0000000000.01
Changes in Working Capital -0000.05-0.010.080.51-0.470.09-0.05
Tax Paid 00000-0.010-0.0100
Cash Flow From Investing Activity 0000000000
Capex 0000000000
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity -0.23-0.020.020-0.17-0.260000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others -0.23-0.020.020-0.17-0.260000
Net Cash Flow -0.31-0.030.060.18-0.20-0.140.52-0.500.01-0.02
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)-159.53-1.768.48-48.73-4.5912.22.02-13.95-38.448.66
ROCE (%)-150.53-1.759.13-32.23-1.877.981.37-3.7-13.13.84
Asset Turnover Ratio00.420.623.420.781.360.592.31.541.43
PAT to CFO Conversion(x)N/AN/A1.33N/AN/A452N/AN/A-0.67
Working Capital Days
Receivable Days033212919710819280172184
Inventory Days0000000000
Payable Days00100191257431910

Checkpoint Trends Ltd Stock News

Checkpoint Trends Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Rubra Medicaments on 21-Nov-2024 16:59 is ₹13.26.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Rubra Medicaments stood at ₹7.40.
The latest P/E ratio of Rubra Medicaments as of 21-Nov-2024 16:59 is 0.00.
The latest P/B ratio of Rubra Medicaments as of 21-Nov-2024 16:59 is 14.43.
The 52-week high of Rubra Medicaments is ₹17.45 and the 52-week low is ₹4.09.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Rubra Medicaments is ₹0.79 ( Cr.) .

About Checkpoint Trends Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.